← Back to Search

Endoprosthesis

GORE VIABHAN Endoprothesis for Peripheral Vascular Disease (VIPER Trial)

N/A
Waitlist Available
Led By Richard Saxon, MD
Research Sponsored by W.L.Gore & Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

The objective of the study is collect data on the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in the treatment of chronic Superficial Femoral Artery disease. Device patency at 12 months is the primary endpoint.

Eligible Conditions
  • Peripheral Vascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Patency at 12 Months
Secondary study objectives
Device-related Major Adverse Events at 12 Months
Primary Assisted Patency
Proportion of Subjects Who Experience Major Device-related Adverse Events Within the First 30 Days
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: GORE VIABHAN EndoprothesisExperimental Treatment1 Intervention
Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
2007
N/A
~120

Find a Location

Who is running the clinical trial?

W.L.Gore & AssociatesLead Sponsor
99 Previous Clinical Trials
31,125 Total Patients Enrolled
Richard Saxon, MDPrincipal InvestigatorNorth County Radiology Medial Group Inc.
1 Previous Clinical Trials
85 Total Patients Enrolled
~7 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top